Navigation Links
Genmab Reaches Milestone in Ofatumumab Collaboration
Date:10/10/2008

Summary: Genmab has Reached the Sixth Milestone in its Ofatumumab

Collaboration With GSK.

COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately DKK 29 million (approximately USD 5.6 million) was triggered by the first patient receiving treatment in the ofatumumab Phase I study in relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia in Japan.

Ofatumumab is an investigational, new generation, human monoclonal antibody that targets a distinct membrane proximal, small loop epitope ( specific binding site) of the CD20 molecule on the surface of B-cells. Ofatumumab is being developed to treat chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co- development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved for sale in any country.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
2. Genmab A/S - Changes Board/Management/Auditors
3. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
4. Genmab Announces 2008 First Quarter Results
5. Passing of Genmab A/S Annual General Meeting
6. Genmab A/S - Notice to Convene Annual General Meeting
7. Genmabs 2007 Annual Report
8. Genmab Announces Year End 2007 Financial Results
9. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
10. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
11. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... results of a new study led by George ... evidence that nucleation of ice in small droplets ... water,s behavior at the nanoscale. The formation of ... scientific research question whose answer also has important ... , The crystallization of ice from supercooled water ...
(Date:5/21/2013)... The congress of the ERA-EDTA ... the biggest congress in Europe ... are in Istanbul to share ... pioneering studies have been presented: / (1) ... VIA HEMODIALYSATE REDUCES ESA USE" By SFP-iron ...
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5
...  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. ... will be presenting at the Seventh Annual Neurotech ... http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The title of ... Attractive Targets for Active and Passive Immunotherapy." His ...
... Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry ... anesthesia drugs with special focus on ketamine, distribution structure of anesthesia drugs ... U.S. and U.S. market entry strategy. Browse market ... Anesthesia Drugs Market (2011 - 2015) -   U.S. ...
... April 12, 2011, nearly fifteen years after she became paralyzed ... by thinking about moving her arm and hand to lift ... drink. That achievement is one of the advances in brain-computer ... May 17 edition of the journal Nature by ...
Cached Biology Technology:Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 2Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 3People with paralysis control robotic arms to reach and grasp using brain computer interface 2People with paralysis control robotic arms to reach and grasp using brain computer interface 3People with paralysis control robotic arms to reach and grasp using brain computer interface 4People with paralysis control robotic arms to reach and grasp using brain computer interface 5
(Date:5/21/2013)... most deadly when they metastasize and spread tumors throughout ... becomes very difficult for doctors to locate and treat ... the University of Missouri have found a way to ... they may be in the body. Michael Lewis, an ... Veterinary Medicine, says being able to target secondary tumors ...
(Date:5/21/2013)... uphill battle? Try staying fit in space, where living ... bone. , That,s the challenge a group of Michigan ... $1.2 million grant from NASA. Their goal is to ... , "You could give astronauts the best exercise regimen ... stick to it, it isn,t going to help," said ...
(Date:5/21/2013)... scientists have charted the path of insulin action in ... a comprehensive blueprint for understanding what goes wrong in ... Humphrey and Professor David James from Sydney,s Garvan Institute ... online edition of the prestigious journal Cell Metabolism ... plays a very important role in the body because ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... In humans, the eyes are said to be the window ... intentions. New research demonstrates for the first time that birds ... to look at their prey when they attack, so direct ... at the University of Bristol, and her colleagues, set up ...
... could be harmful to the environment. For years, scientists ... and, recently, have used this knowledge to create consumer ... researcher has found that silver nanoparticles also may destroy ... wastewater treatment systems. The study was funded by a ...
... (April 29, 2008) Researchers discovered a legless lizard ... new species in Brazils Cerrado, one of the worlds ... once covered an area half the size of Europe, ... at twice the rate of the neighboring Amazon rainforest, ...
Cached Biology News:Are you looking at me? 2Too much technology may be killing beneficial bacteria 2New species discovered in Brazil 2
... 16-independent channels for automated gigaseal patch clamping. ... against voltage-gated ion channels, such as hERG ... The four pipette heads afford more ... channel drug discovery. The glass-coated tunnels ...
... Plating Beads Sterile plating in just ... rods and potentially hazardous ethanol flaming, More ... of ready-to-use sterile packaging: dispenser bottle for spreading ... Fastest and easiest way to spread ...
... successful cell culture or fermentation is the ... process, and make rapid adjustments in response ... Chemistry Analyzers provide immediate analysis of key ... and fermentation media. BioProfile analyzers are fully ...
... 17 amino acid synthetic peptide whose sequence is from rat SCAMP ... terminus): C - N(217) - Q - P - Q ... T - P - N - Y - T - Y ... for neutralization and control experiments with the polyclonal antibody that reacts ...
Biology Products: